Inhibition of cell survival, cell cycle progression, tumor growth and cyclooxygenase-2 activity in MDA-MB-231 breast cancer cells by camphorataimide B

European Journal of Pharmacology

Volumn 680, Issue 1-3, 2012, Pages 8-15

  Lin, Wea Lung ^a,b   Lee, Yean Jang ^c   Wang, Shao Ming ^b   Huang, Pei Yun ^d   Tseng, Tsui Hwa ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHANGHUA UNIVERSITY OF EDUCATION   (Taiwan)

^d Institute of Biochemistry and Biotechnology   (Taiwan)

Author keywords

Breast cancer; Camphorataimide B; Cell cycle; Cyclooxygenase 2

Indexed keywords

CAMPHORATAIMIDE B; CAMPHORATAIMIDE C; CYCLIN A; CYCLIN B1; CYCLOOXYGENASE 2; MALEIMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTRODIA; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN A; CYCLIN B; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; FEMALE; HUMANS; KI-67 ANTIGEN; MALEIMIDES; MICE; MICE, NUDE; MYCELIUM; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84862782587     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.01.032     Document Type: Article

References (25)

1. Z.H. Ao, Z.H. Xu, Z.M. Lu, X.M. Zhang, and W.F. Dou Niuchangchih (Antrodia camphorate) and its potential in treating liver diseases J. Ethnopharmacol. 121 2009 194 212
2. G.D. Basu, L.B. Pathangey, T.L. Tinder, M. LaGiola, S.J. Gendler, and P. Mukherjee Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer Mol. Cancer Res. 2 2004 632 642 (Pubitemid 39557666)
3. G.D. Basu, L.B. Pathangey, T.L. Tinder, S.J. Gendler, and P. Mukherjee Mechanisms underlying the growth inhibitory effects of the cyclooxygenase-2 inhibitor celecoxib in human breast cancer cells Breast Cancer Res. 7 2005 422 435
4. R.D. Blumenthal, C. Waskewich, D.M. Goldenberg, W. Lew, C. Fleflech, and J. Burton Chronotherapy and chronotoxicity of th ecyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts Clin. Cancer Res. 7 2001 3178 3185 (Pubitemid 32963841)
5. Y. Cao, and S.M. Prescott Many actions of cyclooxygenase-2 in cellular dynamics and in cancer J. Cell. Physiol. 190 2002 279 286 (Pubitemid 34111968)
6. S.H. Chang, C.H. Liu, and R. Conway Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression Proc. Natl. Acad. Sci. U. S. A. 101 2004 591 596 (Pubitemid 38084681)
7. 2 or Zn/AcOH stereoselective reduction Tetrahedron 64 2008 4347 4354
8. S.C. Chien, M.L. Chen, H.T. Kuo, Y.C. Tsai, B.F. Lin, and Y.H. Kuo Anti-inflammatory activities of new succinic and maleic derivatives from the fruiting body of Antrodia camphorate J. Agric. Food Chem. 56 2008 7017 7022
9. G. Davies, J. Salter, M. Hills, L.A. Martin, N. Sacks, and M. Dowsett Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer Clin. Cancer Res. 9 2003 2651 2656 (Pubitemid 36842109)
10. G.I. Evan, and K.H. Vousden Proliferation, cell cycle and apoptosis Nature 411 2001 342 348
11. R.E. Harris, R.T. Chlebowski, R.D. Jackson, D.J. Frid, J.L. Ascenseo, G. Anderson, A. Loar, R.J. Rodabough, E. White, and A. McTiernan Breast cancer and nonsteroidal anti-inflammatory drugs Cancer Res. 63 2003 6096 6101
12. T.L. Larkins, M. Nowell, S. Singh, and G.L. Sanford Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression BMC Cancer 6 2006 181 192
13. X.H. Liu, and D.P. Rose Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines Cancer Res. 56 1996 5125 5127 (Pubitemid 26383023)
14. J.J. Liu, T.S. Huang, M.L. Hsu, C.C. Chen, W.S. Lin, F.J. Lu, and W.H. Chang Antitumor effects of the partially purified polysaccharides from Antrodia camphorata and the mechanism of its action Toxicol. Appl. Pharmacol. 201 2004 186 193
15. S.M. Meeran, and S.K. Katiyar Cell cycle control as a basis for cancer chemoprevention through dietary agents Front. Biosci. 13 2008 2191 2202 (Pubitemid 351589245)
16. N. Nakamura, A. Hirakawa, J.J. Gao, H. Kakuda, M. Shiro, Y. Komatsu, C.C. Sheu, and M. Hattori Five new maleic and succinic acid derivatives from the mycelium of Antrodia camphorata and their cytotoxic effects on LLC tumor cell line J. Nat. Prod. 67 2004 46 48 (Pubitemid 38141309)
17. R. Pai, T. Nakamura, W.S. Moon, and A.S. Tarnawski Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors FASEB J. 17 2003 1640 1647 (Pubitemid 37100065)
18. A. Ristimäki, A. Sivula, J. Lundin, M. Lundin, T. Salminen, C. Haglund, H. Joensuu, and J. Isola Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer Cancer Res. 62 2002 632 635 (Pubitemid 34126931)
19. C.C. Shen, H.C. Yang, R.L. Huang, J.C. Chen, and C.C. Chen Anti-HBV principle from the culture broth of Antrodia camphorate (strain # CCRC-35396) J. Chin. Med. 14 2005 247 258
20. Z.T. Tsai, and S.L. Liaw The Use and the Effect of Ganoderma 1985 San Yun Press Taiwan 116 117
21. K. Vermeulen, D.R. Van Bockstaele, and Z.N. Berneman The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer Cell Prolif. 36 2003 131 149 (Pubitemid 36808270)
22. M. Wagemakers, G.E. van der Wal, R. Cuberes, I. Álvarez, E.M. Andrés, J. Buxens, J.M. Vela, H. Moorlag, J.J.A. Mooij, and G. Molema COX-2 inhibition combined with radiation reduces orthotopic glioma outgrowth by targeting the tumor vasculature Transl. Oncol. 2 2009 1 7
23. S.H. Wu, L. Ryvarden, and T.T. Chang Antrodia camphorata ("niu-chang-chih"), new combination of a medicinal fungus in Taiwan B.B.A.S. 38 1997 273 275 (Pubitemid 27496370)
24. F.C. Yang, and C.B. Liau Effects of cultivating conditions on the mycelial growth of Ganoderma lucidum in submerged flask cultures Bioprocess. Eng. 19 1998 233 236
25. M. Zang, S.W. Cui, P.C.K. Cheung, and Q. Wang Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characterixtics and antitumor activity Trends Food Sci. Technol. 18 2007 4 19 (Pubitemid 44827599)